Robert J Rushakoff
University of California, San Francisco · 149 works · 3,147 citations · h-index 22
Top works
- Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis.
- Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors
- Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline
- Association Between a Virtual Glucose Management Service and Glycemic Control in Hospitalized Adult Patients
- Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans.
- Consensus Statement on Inpatient Use of Continuous Glucose Monitoring
- Effects of Pregnancy and Sex Steroid Administration on Skeletal Muscle Metabolism in the Rat
- Glucose delivery — A clarification of its role in regulating glucose uptake in rat skeletal muscle
- Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline
- Physiological Concentrations of Cholecystokinin Stimulate Amino Acid-Induced Insulin Release in Humans*
- Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors – Lessons From a Case Series and Strategies to Decrease Incidence
- Evaluation of a “Formal” Endocrinology Curbside Consultation Service: Advice by Means of the Internet, Fax, and Telephone
- Reduced postprandial cholecystokinin (CCK) secretion in patients with noninsulin-dependent diabetes mellitus: evidence for a role for CCK in regulating postprandial hyperglycemia
- A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic
- Impact of an Interactive Online Nursing Educational Module on Insulin Errors in Hospitalized Pediatric Patients
- Management of diabetes and hyperglycemia in the hospital: A practical guide to subcutaneous insulin use in the non-critically ill, adult patient
- Relative Effects of Pregnancy and Corticosterone Administration on Skeletal Muscle Metabolism in the Rat*
- Falsely Decreased Hba1c in A Type 2 Diabetic Patient Treated with Dapsone
- Regulation of Pancreatic Endocrine Function by Cholecystokinin: Studies with MK-329, a Nonpeptide Cholecystokinin Receptor Antagonist*
- Patient Self-Management of Diabetes Care in the Inpatient Setting